Company: Sun Pharmaceutical Industries Ltd. Category: Independent Research

Ranvir Singh of Systematix Shares joins in and gives his view on which way one should be looking at Sun Pharma Listen in!
Dec. 6, 2018, midnight

HDFC Securities is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 670 in its research report dated August 16, 2018.
Aug. 21, 2018, 5:06 p.m.

Shares of Sun Pharma hit 5-month high as the USFDA has accepted the company's new drug application. The stock climbed as much as 6.4 per cent to Rs. 576, highest since July 27
Dec. 27, 2017, 11:17 a.m.

We know Sun Pharmaceutical stock hit 1000 in 2015 Q1, now it's below 500. Is it good to invest in this stock now? Will it come back and give good returns by 2020? - Quora
Sept. 15, 2017, 10:09 a.m.

  • 1